Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 01. August 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 9022  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 180438  
   
Performance of Urine Tumor DNA Detection in Patients with High-grade Non-muscle-invasive Bladder Cancer Undergoing Repeat Transurethral Resection.
Eur Urol Focus
Ogunkeye J, Shkolyar E, Mach KE, Prendiville S, Prado K, Shah JB, Skinner EC, Fischer DS, Phillips KG, Bicocca VT, Levin TG, Liao JC.
PMID: 42538173 [PubMed - as supplied by publisher]


Activation of the PI3K/AKT/mTOR signaling pathway in bladder cancer pathogenesis and its therapeutic significance.
Cancer Treat Res Commun
Bogale DE.
PMID: 42537446 [PubMed - as supplied by publisher]


Venous thromboembolism in urothelial bladder cancer - scope of the problem and patients' perspectives: VTE-UBC.
Wiad Lek
Abdullah OR, Short K, Alomari LHF, Ignatowicz A, Young A.
PMID: 42536929 [PubMed - indexed for MEDLINE]


Homologous Recombination and Mismatch Repair Assessment in Men With Advanced Prostate Cancer: A Cross-Sectional Study From a Center in Mexico City.
Oncology (Williston Park)
Rodríguez-Olivares JL, Mauricio Mora Pineda Md, Beas-Lozano E, Alec Seidman-Sorsby Md, Remolina-Bonilla YA, Armando Gamboa-Domínguez Md, Jeffrey Weitzel Md Facmg, Pedro Barata Md MSc, Yanin Chavarri-Guerra Md MSc Fasco, Bourlon MT.
PMID: 42536596 [PubMed - indexed for MEDLINE]


An immunohistochemical diagnostic panel for Xp11.2 translocation renal cell carcinoma: A diagnostic accuracy study.
Medicine (Baltimore)
Wei M, Pan B, Yang W, Xu W, Dong J.
PMID: 42536557 [PubMed - indexed for MEDLINE]


Risk of bladder cancer among male participants reporting nocturia in the Cancer Prevention Study-II.
Cancer Epidemiol Biomarkers Prev
Zhong C, Masters M, Donzella SM, Bliwise DL, Parsons H, Rees-Punia E.
PMID: 42536351 [PubMed - as supplied by publisher]


Circadian Gene Networks and Transcriptome Oscillations in Prostate Cancer: Insights From RNA Sequencing and Implications for Chronotherapy.
Cureus
Bivolarski I, Dimitrov M, Dechev H.
PMID: 42535191 [PubMed]


Indian Delphi consensus on cardiovascular risk mitigation in prostate cancer management.
Front Oncol
Bakshi G, Lyon A, Joshi A, Agarwala V, Raghunath SK, Addla SK, Taneja R, Mandani A, Kashyapi B, Bhargava S, Sharma R, Agrawal V, Nagar R, Srivathsan R, Patel K, Patel R, Shah H, Lai A, Mukherjee A, Pandey S, Rajput A.
PMID: 42534891 [PubMed]


AI-driven precision diagnosis and treatment of prostate cancer: a narrative review.
Front Oncol
Chu T, Zhang Y, Du J, Mierxiati A.
PMID: 42534734 [PubMed]


Apalutamide-induced prostate-specific antigen response and its association with clinical outcomes in metastatic castration sensitive prostate cancer (Review).
Mol Clin Oncol
N S, Mv C, Upadhyay A, Sonone P, Dharmadhikari S, Puppalwar G, Khandhedia C, Mane A, Mehta S.
PMID: 42534213 [PubMed]


[(18)F]PSMA-1007 PET-Based Recurrence Site Distribution and Predictors of Metastatic Disease in Patients With Biochemical Recurrence of Prostate Cancer.
Int J Urol
Hatano K, Watabe T, Hirata T, Konishi M, Kanaki T, Tani M, Oka T, Ishizuya Y, Hayashi T, Yamamoto Y, Kato T, Kawashima A, Fujita K, Uemura M, Giesel FL, Nonomura N.
PMID: 42533777 [PubMed - indexed for MEDLINE]


Oncological Outcomes and Prognostic Factors of Platinum-Based Chemotherapy Followed by Avelumab Maintenance Therapy Compared With Platinum-Based Chemotherapy Alone: A Propensity Score-Matched Analysis in a Real-World Population.
Int J Urol
Matsushita Y, Kita Y, Mukai S, Joraku A, Kobayashi I, Daizumoto K, Sano T, Nakanishi S, Watanabe J, Hatakeyama S, Goriki A, Hazama T, Nishiyama N, Mori K, Kitamura H, Kimura T, Matsui Y, Miyake M, Kobayashi T, Inamoto T, Japanese Urological Oncology Group.
PMID: 42533764 [PubMed - indexed for MEDLINE]


Full-Component Chart-Derived Lee Score, Upfront Androgen Receptor Signaling Inhibitor Selection, and Competing Mortality in Metastatic Hormone-Sensitive Prostate Cancer.
Geriatr Gerontol Int
Kurokawa K, Yamamoto S, Higa K, Bamba H, Kanaoka S, Nakamura K.
PMID: 42533722 [PubMed - indexed for MEDLINE]


Challenges of Bone Scintigraphy in Assessment of Osseous Metastases in Prostate Cancer: Why it is Time to Reconsider Role of (1)â¸F-NaF PET/CT.
Mol Imaging Biol
Zirakchian Zadeh M.
PMID: 42533239 [PubMed - as supplied by publisher]


Tumor and Organ Dose Estimates from (177)Lu-PSMA-617 Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: Results from the RESIST-PC Phase 2 Trial.
J Nucl Med
Ells Z, Meyer C, Masri K, Ryhiner M, Sennung D, Kimura K, Mirando D, Tworowska I, Esfandiari R, Allen-Auerbach MS, Lassmann M, Herrmann K, Eiber M, Fendler WP, Delpassand E, Czernin J, Dahlbom M, Calais J.
PMID: 42532646 [PubMed - as supplied by publisher]


Environmental exposome study for prostate cancer in elderly men from Western China: preliminary findings from a case-control study in the WeEndPd cohort.
BMJ Open
Zhou X, He Y, Jin Y, Peng Z, Zeng B, Zhang Z, Wu Y, Wei C, Mo Z, Cheng J, Chen Y, Wang F, Lu G, Tao K, Yang Z, Wu Y, Zhang W, Zhuang C, Guo W, Li G, Liu Y, Huang Y, Gao R, Zhan Y, Zou X, Yang L, Wei Q, Wei X, Qiu S.
PMID: 42532568 [PubMed - indexed for MEDLINE]


[Testicular Germ Cell Tumors and Penile Cancer: Molecular-Based Diagnosis and Treatment].
Aktuelle Urol
Paffenholz P, Heidenreich A, Weiten R.
PMID: 42532107 [PubMed - as supplied by publisher]


Can prostate cancer be diagnosed with near certainty on MRI?
Eur J Radiol
Cummings C, Allen C, Dickinson L, Pendse D, Emberton M, Giganti F, Moore C, Woernle A, Freeman A, Haider A, Kirkham A.
PMID: 42531699 [PubMed - as supplied by publisher]


Assessing Geographic Disparities in the Availability of Renal Cell Carcinoma Clinical Trials in the United States.
JCO Oncol Pract
Zhang G, Fann J, Castro DV, Shah KU, Li X, Abreu de Goes V, Jaime-Casas S, Mercier B, Li YJ, Agarwal R, Dickter S, Dukkipati A, Goud J, Lau L, Lau LM, Lee J, Shah K, Simon R, Swarat E, Zugman M, Moradi A, Hsu J, Dizman N, Nguyen C, Chehrazi-Raffle A, Barragan-Carrillo R, Pal SK.
PMID: 42531525 [PubMed - as supplied by publisher]


Prognostic significance of TOP2A expression in bladder cancer: Systematic review and meta-analysis.
Can Urol Assoc J
Hendri AZ, Robert R, Febriyanto T, Liliana B, Pratama ADM, Oey O.
PMID: 42531453 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 180438    Seite 1 von 9022  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1